Western University Researchers Identify New Genetic Mutation for ALS

Strong’s team is convinced ALS is a disorder of RNA metabolism. RNA is the intermediary or messenger between genes and the protein being made. This new protein appears to play a critical role. “Every time we look at a cell degenerating, this particular protein was deposited abnormally in the cell. It was a common denominator,” explains Strong, who is also the Dean of Schulich Medicine & Dentistry. “Working with Dr. Rob Hegele at Robarts, we found there was a genetic mutation in the gene coding for this protein. So it’s a huge discovery.”

Categories: Research News, Treatments  |  Tags: ALS, ALS community, ALS cure, ALS medical care, ALS research, ALS research funding, ALS treatments, amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, ARHGEF28 gene ALS, Bob Stehlin, Canada ALS, Dr. Michael Strong ALS, Dr. Rob Hegele, Lou Gehrig's disease, PALS, RASCALS Foundation, RNA metabolism ALS, Robarts Research Institute, Robert A. Stehlin Campaign for ALS, Schulich School of Medicine & Dentistry, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, Western University in London, World Federation of Neurology Research Group on Motor Neuron Disease  |  No comments